Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Y-27632

Generic Name: Y-27632

Drug Type: Small Molecule

Chemical Formula: C_₁₄H_₂₁N_₃O

CAS Number: 146986-50-7

Unique Ingredient Identifier: 0X370ROP6H

Overview

Y-27632 is an inhibitor of Rho-associated protein kinase. It inhibits calcium sensitization to affect smooth muscle relaxation.

Background

Y-27632 is an inhibitor of Rho-associated protein kinase. It inhibits calcium sensitization to affect smooth muscle relaxation.

Indication

No indication information available.

Associated Conditions

No associated conditions information available.

Clinical Trials

A Safety and Efficacy Study of Corneal Injection for Endothelial Dysfunction Using Human Corneal Endothelial Cell Therapy in Subjects With Corneal Edema Secondary to Endothelial Dysfunction

Phase 1

Completed

Posted: 2022/04/04

Sponsor:

Aurion Biotech

ID:NCT05309135

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Related News

Alcon Acquires Majority Stake in Aurion Biotech to Advance First-Ever Corneal Cell Therapy

2 months ago

Alcon has acquired a majority interest in Aurion Biotech, positioning itself at the forefront of ophthalmic cell therapy with AURN001, which has received Breakthrough Therapy and Regenerative Medicine Advanced Therapy designations from the FDA.

Aurion Biotech's AURN001 Shows Promise in Phase 1/2 Trial for Corneal Edema

5 months ago

Aurion Biotech's AURN001, an allogeneic cell therapy, demonstrated statistically significant improvement in visual acuity in patients with corneal edema in a Phase 1/2 trial.

Error parsing response

6 months ago

Error occurred while parsing the model response.

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Home Terms & Conditions Privacy Policy